Dynavax appoints chief medical officer
This article was originally published in Scrip
Dynavax, a clinical-stage biopharmaceutical company developing products to treat infectious and inflammatory diseases, has appointed Dr Robert Janssen chief medical officer. Prior to joining Berkeley, California-based Dynavax, Dr Janssen was vice-president of medical affairs at Gilead. He also spent 23 years at the US Centers for Disease Control and Prevention (CDC), most recently as the director of the Division of HIV/AIDS Prevention.